Cleared Traditional

K112236 - WONDFO METHYLENEDIOXYMETHAMPHETAMINE URINE TEST, WONDFO MORPHINE URINE TEST (FDA 510(k) Clearance)

Sep 2011
Decision
46d
Days
Class 2
Risk

K112236 is an FDA 510(k) clearance for the WONDFO METHYLENEDIOXYMETHAMPHETAMINE URINE TEST, WONDFO MORPHINE URINE TEST. This device is classified as a Gas Chromatography, Methamphetamine (Class II - Special Controls, product code LAF).

Submitted by Guangzhou Wondfo Biotech Co., Ltd. (Gaithersburg, US). The FDA issued a Cleared decision on September 19, 2011, 46 days after receiving the submission on August 4, 2011.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.3610.

Submission Details

510(k) Number K112236 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 04, 2011
Decision Date September 19, 2011
Days to Decision 46 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code LAF — Gas Chromatography, Methamphetamine
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.3610

Similar Devices — LAF Gas Chromatography, Methamphetamine

SEFRIA Methamphetamine Oral Fluid Enzyme Immunoassay
K203647 · Immunalysis Corporation · Dec 2021
Rapid Tox Cup II
K170222 · American Bio Medica Corp. · Aug 2017
Immunalysis Methamphetamine Urine Enzyme Immunoassay, Immunalysis Multi-Drug Calibrators
K153693 · Immunalysis Corporation · Mar 2016
Healgen MDMA (Ecstacy) Test (Strip, Cassette, Cup, Dip Card), Healgen Phencyclidine Test (Strip, Cassette, Cup, Dip Card)
K150096 · Healgen Scientific, LLC · Mar 2015